These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 824473)

  • 1. Aminoacid imbalance ratio in liver disease.
    Maqsood R; Zuberi SJ
    J Pak Med Assoc; 1976 Jun; 26():145-6. PubMed ID: 824473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoacid imbalance ratio in liver disease.
    Maqsood R; Zuberi SJ
    J Pak Med Assoc; 1976 Jun; 26(6):145-6. PubMed ID: 826659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the erythrocyte membrane and the serum lipids in acute hepatitis and liver cirrhosis].
    Pristautz H; Stübchen-Kirchner H; Fereberger W
    Wien Med Wochenschr; 1978 Feb; 128(4):99-103. PubMed ID: 636447
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of pigment metabolism in patients with chronic viral hepatitis and liver cirrhosis].
    Bochkova LM; Voronova GV
    Ter Arkh; 1976; 48(12):35-9. PubMed ID: 1013892
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced thyroidal uptake of inorganic iodine in liver cirrhosis.
    Sakurabayashi S; Sezai S; Yamamoto Y; Yoshino K; Hirano M; Iwase T; Oka H; Okano K
    J Med; 1996; 27(3-4):193-204. PubMed ID: 8982967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on expression of transforming growth factor-beta 3 in the liver tissues].
    Wang Y; Wang L; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):61-3. PubMed ID: 12515175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of serum carnitine in patients with liver diseases].
    Lin XH; Jiao LL; Xu GB; Tian GS
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on expression of P16 protein in the liver tissue of viral hepatitis].
    Xin S; Wang L; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):122-4. PubMed ID: 12515187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of clofibrate in hepatitis and liver cirrhosis].
    Hartlapp JH; Kürten J; Gugler R
    Verh Dtsch Ges Inn Med; 1978; (84):1108-10. PubMed ID: 741896
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional activity of protein C in liver cirrhosis and acute viral hepatitis on the Ivory Coast.
    Blavy G; Nasreddine ML; Kouassi D
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):339-40. PubMed ID: 7971257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascites.
    Knauf H; Missmahl M; Schölmerich J; Gerok W; Mutschler E
    Arzneimittelforschung; 1987 Dec; 37(12):1385-8. PubMed ID: 3449068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The behavior of albumin in acute and chronic liver damage. III. Intrahepatic and serum albumin concentrations in human liver diseases].
    Rogos R
    Z Gesamte Inn Med; 1978 Aug; 33(15):506-12. PubMed ID: 695790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of parenteral amino acid administration on the brain function and the serum aminogram of patients with liver cirrhosis].
    Leweling H; Knauff HG; Nitschke J; Paquet KJ
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):88-94. PubMed ID: 6776054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
    El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
    Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
    Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases.
    Horiike N; Abe M; Kumagi T; Hiasa Y; Akbar SM; Michitaka K; Onji M
    Clin Biochem; 2005 Jun; 38(6):531-4. PubMed ID: 15885232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of branched-chain amino acid-enriched nutrient mixture on natural killer cell activity in viral cirrhosis.
    Takegoshi K; Nanasawa H; Itoh H; Yasuyama T; Ohmoto Y; Sugiyama K
    Arzneimittelforschung; 1998 Jun; 48(6):701-6. PubMed ID: 9689432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.